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Summary
Objective: To characterize a novel secreted frizzled-related protein (SFRP) and determine its tissue distribution at the mRNA and protein
level.
Methods: The FrzB-2 gene was identified by expressed sequence tag (EST) analysis of human tissue-derived libraries. Tissue distribution
of FrzB-2 mRNA was determined by Northern blot analysis and in situ hybridization. FrzB-2 protein reactivity was localized in human OA
articular cartilage by immunocytochemistry, using a polyclonal antibody against a peptide sequence unique to FrzB-2. Apoptosis was
detected in articular cartilage sections using Tunel staining.
Results: ESTs corresponding to FrzB-2 were found in osteoblast, chondrosarcoma, osteosarcoma, osteoclastoma and synovial fibroblast
libraries. FrzB-2 mRNA is expressed in a number of tissues and cell types including bone-related cells and tissues such as primary human
osteoblasts and osteoclastoma. In situ hybridization studies showed strong FrzB-2 mRNA expression in human chondrocytes in human
osteoarthritic (OA) cartilage but negligible levels in normal cartilage chondrocytes. The FrzB-2 cDNA encodes a secreted 40 kDa protein
consisting of 346 amino acids. FrzB-2 is 92.5% identical to the rat orthologue, DDC-4, which has been shown to be associated with
physiological apoptosis. FrzB-2 protein was selectively detected in human OA articular cartilage by immunocytochemistry, using a polyclonal
antibody. Consistent with its potential role in apoptosis, positive FrzB-2 staining and Tunel positive nuclei staining were detected in
chondrocyte clones in sections of human OA cartilage.
Conclusion: These data suggest that FrzB-2 may play a role in apoptosis and that the expression of this protein may be important in the
pathogenesis of human OA. © 2000 OsteoArthritis Research Society International
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The Wnts represent a large group of secreted signaling
proteins that are involved in cell proliferation and differ-
entiation1 and play pivotal roles in morphogenesis. Frizzled
genes encode 7-transmembrane proteins which act as
receptors for Wnt proteins.2 Recently, a secreted frizzled-
related protein family (SFRP) was described. Members of
this family share the Wnt binding domain of the frizzled
proteins but lack their 7-transmembrane segments. It has
been suggested that these SFRP proteins may control
morphogenesis by binding Wnts extracellularly3,4 and
antagonize their ability to signal through the plasma
membrane-bound frizzled receptors. In addition, it has
been demonstrated that at least one SFRP, termed FrzB-1,
can interact with Wnt 5A but does not appear to act as
an antagonist,5 suggesting that SFRPs may also act as
chaperones for the Wnts. A prominent feature of both the452frizzled receptors and their soluble counterparts is the
presence of a cysteine-rich domain (CRD) implicated in
Wnt ligand binding.6 The CRD, termed the frizzled motif,7
consists of a conserved region of approximately 120 amino
acids, containing 10 cysteine residues that are conserved
among the members of this family. It has been suggested
that sequence variance between the conserved cysteine
residues may provide the specificity of different Wnt ligand
binding for the various CRDs. The frizzled motif has been
found in other protein families including type-XVIII collagen,
carboxypeptidase Z and two subfamilies of the receptor
tyrosine kinases,8,9 but their respective roles remain to be
elucidated. The SFRP family also possesses a C-terminal
netrin domain. This is a modular domain of unclear
function, shared with several other protein families, includ-
ing netrins (axonal guidance molecules), procollagen
C-proteinase enhancer proteins (PCOLCEs), com-
plement proteins C3, C4, C5 and tissue inhibitors of
metalloproteinases (TIMPs).10
FrzB-1, a homologue of FrzB-2 (48.6% identical at the
protein level), is also expressed in human cartilage during
development. In addition, a FrzB-1-containing extract was
shown to have in vivo chondrogenic activity in rats.11 TheseAddress correspondence to: Ian E. James Ph.D., Department
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Osteoarthritis and Cartilage Vol. 8 No. 6 453data suggest that FrzB-1 may play an important role in both
skeletal morphogenesis and maintenance of the mature
skeleton.
Apoptosis is a normal physiological process that is
involved in maintaining normal cell and tissue homeostasis.
However, aberrant apoptosis can result in pathologicalconditions such as Alzheimer’s disease12 and neuronal
cell death following spinal cord injury.13 Recently, apoptotic
cell death has been observed in human osteoarthritic
articular cartilage14 and in an animal model of osteoarthritis
(OA), suggesting that apoptosis may play a role in the
pathogenesis of this disease.Fig. 1. Nucleotide and amino acid sequence of the full-length human FrzB-2. The open reading frame of the FrzB-2 gene encodes
a polypeptide of 346 amino acids with a putative signal sequence (gray shaded box). The cysteine-rich domain (CRD) is underlined, with
the conserved cysteine residues in boxes. The peptide sequence used to raise the anti-FrzB-2 polyclonal antibody is highlighted in the
black box.
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such as the SARPs (secreted apoptosis-related proteins)
have the ability either to sensitize cells to apoptosis or to
inhibit the apoptotic response.15 Furthermore, Wolf and
co-workers16 described a rat gene, termed DDC-4, that
was upregulated during physiological apoptosis in ovary
and prostate tissues. In this report, we describe the identi-
fication and characterization of human FrzB-2. Based on
their high identity, human FrzB-2 is likely to be the human
orthologue of rat DDC-4 (92.5% identical at the amino acid
level) and mouse SFRP4 (92% identical). FrzB-2 also
appears to be associated with apoptotic chondrocytes
present in human osteoarthritic cartilage.
Materials and methods
TISSUES
All human tissues for in situ hybridization and immuno-
cytochemistry were obtained with informed consent
through the Hospital of the University of Pennsylvania
(Dr Paul Lotke, Philadelphia, PA, U.S.A.) and the
International Institute for the Advancement of Medicine
(Scranton, PA, U.S.A.). The disease state of the articular
cartilage was characterized by the following criteria: (a)
normal cartilage had a smooth, intact superficial zone and
no indication of proteoglycan loss (as determined by tolui-
dine blue staining) from the mid- and deep zones; (b) early
OA damage included slight fissuring of the superficial zone
and loss of proteoglycan from the zones immediately
surrounding the chondrocytes in the mid- and deep zones:
(c) advanced osteoarthritic cartilage included deep and
extensive fissuring of the superficial zone with characteris-
tic cloning of chondrocytes and extensive proteoglycan loss
throughout the mid- and deep zones.
RNA ISOLATION AND NORTHERN BLOT ANALYSIS
Total RNA was isolated from various primary cells
and cell lines using the Trizol reagent, according to the
manufacturer’s protocol (Life Technologies, Gaithersburg,
MD, U.S.A.). In addition, a commercial human multipletissue Northern blot was processed according to manu-
facturer’s instructions (Clontech, Palo Alto, CA, U.S.A.).
Northern blot analysis was performed with 32P-labeled
FrzB-2 cDNA using standard procedures.17
CLONING OF FRZB-2 CDNAS AND EXPRESSION OF RECOMBINANT
PROTEIN
The full length gene for FrzB-2 was cloned into the
pCMVsport II vector and was subsequently subcloned into
pFASTBAC I utilizing the Sma I and Spe I restriction
endonuclease sites. This clone was further modified at the
5′ end to remove 5′UTR and improve the Kozak sequence
before the start codon. An additional construct was made to
add a C-terminal His6 tag.
Both constructs were transformed into DH10BAC E. coli
and Bacmid DNA was isolated following the protocols
supplied by GIBCO-BRL Life Technologies BAC-to-BAC
baculovirus expression system. Bacmid DNA was then
transfected into Sf9 (Spodoptera frugiperda) cells accord-
ing to the suppliers protocol. Recombinant virus was
harvested in conditioned media after incubation for 4 days
at 27°C. Viral stocks were amplified once in Sf9 cells. All
viral stocks were stored at 4°C in the dark.
Expression of FrzB-2 was carried out by infecting Sf9
cells. Cells were grown in flasks shaking at 120 rpm, and
harvested by centrifugation at 3500 rpm. Samples of
culture media, whole cells and cell lysates were analysed
by SDS-PAGE and Western blot analysis, using either
anti-FrzB-2 or anti-His6 antibodies.
IN SITU HYBRIDIZATION
The FrzB-2 cDNA cloned into pCMVsport2 was
linearized and transcribed using SP6 and T7 promoter sites
to generate the antisense and sense strand riboprobes
using the Promega (Madison, WI, U.S.A.) in vitro transcrip-
tion kit with 35[S]-thio CTP (Amersham, Arlington Heights,
IL, U.S.A.). Following transcription, cDNA templates were
digested with RQ1 RNAse-free DNAse I (Promega), and
unincorporated nucleotides were removed by centrifugationFig. 2(b)
Fig. 2. Alignment and phylogenetic analysis of FrzB-2 and representative members of the secreted frizzled related protein family. (a) Protein
sequence alignments were constructed using ClustalW. The cysteine rich domain (CRD) and netrin domain (NTR) of these proteins are
annotated by shaded and hatched indicators above the sequences. Alignments were adjusted manually to accommodate the known disulfide
bonding and structural features of the NTR domain10 and the CRD. The 14 invariant cysteine residues within the family are highlighted with
asterisks. Arrows indicate cysteine residues which appear conserved within specific subfamilies: subfamily 1 (Sarps): Sarp1, Sarp2 and
Sarp3. Subfamily 2 (FrzBs): FrzB and FrzB-2 (DDC4). Conservation of cysteine residues within subfamilies is particularly apparent within the
netrin domain, suggesting differing netrin domain disulfide bond configurations between each subfamily. Sarp subfamily: C12-C16, C13-C17,
C14-C20. FrzB subfamily: C11-C15, C12-C16, C13-C17, C18-C19. (b) Phylogenetic tree illustrating the relationship between human FrzB-2
(sFRP4), its rat orthologue DDC-4, FrzB and other secreted frizzled related proteins. Primarily based on the differences in their netrin
domains, we propose that the frizzled related proteins fall into two related subfamilies, the SARP and FrzB subfamilies, which may possess
distinct biological properties.
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Mannheim, Indianapolis, IN, U.S.A.). RNA transcripts with a
specific activity in excess of 108 cpm/µg were used for
hybridization.
In situ hybridization was performed on cryostat sections
according to the original method of Zeller and Rogers18,
with modifications described by Dodds et al.19 Air-dried
slides were coated in Amersham LM-1 emulsion and
exposed at 4°C for 2 weeks. The slides were developed in
Kodak developer and counterstained with methylene blue.
The extent of the hybridization signal was assessed by the
autoradiographic grain density over the cell.
RADIATION HYBRID MAPPING
Primers corresponding to the intron/exon boundary in
the FrzB-2 gene sequence were used to amplify the
Genebridge 4 Radiation Hybrid screening panel (Research
Genetics, Huntsville, AL, U.S.A.) using standard PCR con-
ditions. The data were submitted via the World Wide Web
to http://www-genome.wi.mit.edu/cgibin/contig/rhmapper.pl
at the Whitehead Institute for computational and statistical
analysis.POLYCLONAL ANTI-FRZB-2 PEPTIDE ANTIBODY GENERATION
KLH-conjugated and unconjugated peptides derived
from FrzB-2 were synthesized (American Peptide
Company, Inc., Sunnyvale, CA, U.S.A.) and the KLH-
conjugated material was used to immunize rabbits to obtain
polyclonal antibodies (Covance, Denver, PA, U.S.A.). An
antibody raised against the peptide sequence 292QEQR-
RTVQDKKKTA305 was used in the Western blot analyses
and immunocytochemistry studies described below.
WESTERN BLOTTING
The selectivity of the anti-FrzB-2 antibody was confirmed
on baculovirus-expressed recombinant protein. Western
blotting was performed using standard protocols. Briefly,
following SDS-PAGE separation of rhFrzB-2, the protein
was transferred to nitrocellulose. The membrane was
blocked for 2 h in MPBS (5% non-fat milk in phosphate
buffered saline) and then probed for 1 h with the primary
antibody diluted in MPBS. The membrane was washed for
30 min and then overlaid for 1 h with optimally diluted
peroxidase-labeled goat anti-rabbit secondary antibody inFig. 3(a).
Osteoarthritis and Cartilage Vol. 8 No. 6 457MPBS (Dako, Carpinteria, CA, U.S.A.). Protein bands
were visualized using the ECL system (Amersham).
The selectivity of the antibody for FrzB-2 was con-
firmed by pre-incubation with 50 µg/ml of the immunogenic
peptide.
IMMUNOCYTOCHEMISTRY
Microtome sections of formalin-fixed, paraffin-embedded
human cartilage tissues (osteoarthritic and normal) were
prepared for immunocytochemistry and apoptosis detec-
tion. Following deparafinization and rehydration, the sec-
tions were heated in a water bath to 95°C for 20 min in
antigen retrieval buffer (Dako, Carpinteria, CA, U.S.A.). The
slides were cooled for 20 min at room temperature and the
tissues were overlaid with blocking buffer (TBST, 10% goat
serum, 1% human AB serum) for 30 min at room tempera-
ture. Following removal of excess buffer, the sections were
overlaid with optimally diluted (1:400) anti-FrzB-2 antibody.The binding of the primary antibody was visualized using
the LSAB 2 alkaline phosphatase kit and the new fuchsin
substrate/chromogen system, according to the manufac-
turer’s protocols (Dako). A red stain indicates positive
reactivity. The specificity of the staining was determined by
screening negative controls such as the pre-immune serum
from the same rabbit, and by blocking the reactivity of
the anti-FrzB-2 antibody by pre-incubation with FrzB-2
immunogenic peptide (200 µg/ml of peptide for 2 h at room
temperature).
APOPTOSIS
Apoptosis was detected in sections of paraffin-
embedded human articular cartilage (serial to those that
had been probed for FrzB-2 protein expression) using the
ApopTag system, according to the manufacturer’s protocol
(Oncor, Gaithersburg, MD, U.S.A.).Fig. 3(b).
Fig. 3. (a) Distribution of FrzB-2 in bone related cells by Northern blot analysis. Northern blot analysis was performed as described in the
Materials and methods section using RNA derived from a number of bone/cartilage tissues and cell lines. The osteoclastoma stromal cell
sample (lane 1) was derived from cells that had been passaged in culture to remove the osteoclast population of cells. In contrast, the whole
osteoclastoma sample (lane 4) was derived from all the cell populations present in the tissue, including the osteoclasts. The bar graph shows
the tissue expression relative to the appropriate GAPDH control. 1=osteoclastoma stromal cells (osteoclast depleted), 2=primary human
osteoblasts, 3=Saos-2 cells, 4=whole osteoclastoma (stromal cells and osteoclasts), 5=HOS cells (osteosarcoma cell line), 6=MG63 cells
(osteoblast-like cell line), 7=TF-274 cells (osteoblast-like cell line, [33]), 8=HELA cells, 9=mesangial cells, 10=C20-A4 cells (chondrocyte-
like cell line), 11=synovial fibroblasts. The arrow corresponds to a 2.4 Kb FrzB-2 message. (b) Distribution of FrzB-2 mRNA in human tissues
by Northern blot analysis. A commercial multiple tissue Northern blot containing 2 µg of poly-A+ RNA from various human tissues was
probed with 32P-labeled FrzB-2 cDNA. The bar graph shows the tissue expression relative to the appropriate GAPDH control. 1=blood
leukocytes, 2=colon, 3=small intestine, 4=ovary, 5=testis, 6=prostate, 7=thymus, 8=spleen, 9=pancreas, 10=kidney, 11 =skeletal muscle,
12=liver, 13=lung, 14=placenta, 15=brain, 16=heart. The bands correspond to a 2.4 Kb message.
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IDENTIFICATION OF FRZB-2
In an attempt to identify novel homologs of the
smoothened 7-TM receptor, BLAST analysis of the
SmithKline Beecham gene database was performed, using
the nucleotide sequence of smoothened as a query. An
expressed sequence tag (EST) corresponding to a novel
smoothened homolog was found in a human osteoblast
library. One of these ESTs (HOHBP11), when sequenced
was found to contain the full-length sequence of this novel
gene consisting of an open reading frame of 1037 nucleo-
tides encoding a polypeptide of 346 amino acids (Fig. 1).
Using the Lipman–Pearson protein alignment program the
protein shows 48.6% identity with FrzB-1, a secreted
frizzled-related protein. Based on this sequence analysis
the novel protein was named FrzB-2. A search of the public
gene databases indicated that FrzB-2 is identical to a
human sequence, frpHE (accession number: AF026692)
and shows 92.5% homology with a rat apoptosis-related
gene, DDC-4, (accession number: AF012891). These pro-
teins are characterized by the presence of an N-terminal
hydrophobic region (amino acids 1-21 in FrzB-2), which
most likely represents a signal sequence, suggesting that
these proteins are secreted. Downstream of this signal
sequence lies the cysteine-rich domain (CRD), which
comprises approximately 120 residues and includes 10
conserved cysteines (fz-motif) and a number of other
conserved residues, such as prolines (N=8) and leucines
(N=5). In addition to DDC-4, FrzB-2 also shares homology
with the CRD of other human apoptosis-related, secreted
frizzled-related proteins, termed SARP-1, -2, and -3
[Fig. 2(a)]. Members of the SFRP family show reduced
homology across their C-terminal region, which consists
mainly of a netrin (NTR) domain.10 Indeed, a BLAST
search with the C-terminal domain of FrzB-1 or FrzB-2 fails
to detect the SARPs and vice-versa, although all SFRPs
show C-terminal netrin homology. This suggests that
FrzB-1 and FrzB-2 are members of a distinct subfamily to
the SARPs. This is supported by the predicted NTR domain
disulfide bond configurations of each subfamily [see
Fig. 2(a)]; the SARPs have three disulfide bonding pairs in
total, and the FrzBs have four. Only two bonding pairs are
common to both families, suggesting a divergent structure
between these domain, that may indicate different function-
ality between SFRP subfamilies. A phylogenetic analysis of
the SFRP family is shown in Fig. 2(b).
RADIATION HYBRID (RH) MAPPING
The FrzB-2 gene was mapped using the Genebridge 4
RH mapping panel. Gene specific primers place this gene
on human chromosome 7p14.1 within 3.46cR3000 of the
anonymous marker WI-5447. This region is known to
harbor a number of disease loci, including retinitis
pigmentosa 9 and Charcot-Marie-Tooth neuronal type D
neuropathy.
FRZB-2 MRNA IS EXPRESSED IN A NUMBER OF BONE-RELATED
CELL TYPES AND TISSUES BY NORTHERN BLOT ANALYSIS
Overlapping ESTs of this novel gene were found in
chondrosarcoma, osteosarcoma, osteoclastoma and
synovial fibroblast cDNA libraries. Consistent with these
observations, Northern blot analysis revealed that FrzB-2was expressed at high levels in synovial fibroblasts and in
osteoclastoma tissue. FrzB-2 mRNA was expressed in
primary human osteoblasts but not in the osteoblast-like
cell lines, HOS, MG63 and TF274 [Fig. 3(a)]. In addition, no
signal was detected by Northern blot analysis in primary
human chondrocytes, or in the chondrocyte cell line,
C20A4 (data not shown). Using a commercial multiple
tissue Northern blot, significant levels of FrzB-2 RNA were
detected in extracts of ovary, testis, prostate and spleen
and slightly lower levels were found in heart and skeletal
muscle [Fig. 3(b)].
FRZB-2 MRNA IS EXPRESSED IN HUMAN OA CHONDROCYTES BY
IN SITU HYBRIDIZATION
Although no signal was detected by Northern blot analy-
sis in primary chondrocytes, or in the chondrocyte cell line,
C20A4, a strong signal was detected by in situ hybridization
on cryostat sections of human cartilage. Expression of
FrzB-2 mRNA was high in chondrocyte clones in the
superficial zone of advanced osteoarthritic cartilage (Fig. 4
and Table I). Chondrocytes in the mid to deep zones of
these osteoarthritic samples had lower levels of FrzB-2
mRNA and normal cartilage had negligible levels of FrzB-2
mRNA (Table I). The focal and highly localized expression
of FrzB-2 mRNA by in situ hybridization may explain our
inability to detect FrzB-2 mRNA by Northern blot analysis.
EXPRESSION OF RECOMBINANT PROTEIN
The isolation of biologically active recombinant FrzB-2
was not achieved using either the baculovirus expression
system or a mammalian CHO cell expression system (data
not shown). The protein was not secreted and had a
tendency to adhere to the surface of the expressing cells.
The cathepsin K signal sequence has previously been
shown to promote secretion of human cathepsin K; there-
fore, a construct of the cathepsin K signal sequence with
the FrzB-2 CDR was prepared. Even using this signal
sequence, no secretion of FrzB-2 was observed. FrzB-2
protein was detected only in whole cells and in the insoluble
fraction of cell lysates. Consequently, the Western blot data
was generated using lysates of baculovirus infected Sf9
cells.
FRZB-2 PROTEIN EXPRESSION CORRELATES WITH APOPTOSIS BY
IMMUNOCHEMISTRY AND TUNEL STAINING
The rabbit polyclonal anti-FrzB-2 peptide antibody was
shown to be specific for FrzB-2 protein by Western blot
analysis (Fig. 6). The paraffin-embedded sections of nor-
mal articular cartilage were negative for both FrzB-2
immuno-staining and apoptosis (data not shown). In con-
trast, OA-derived articular cartilage sections, in which there
was evidence of fissuring and the presence of chondrocyte
cloning, showed strong FrzB-2 immunostaining and the
presence of large numbers of apoptotic nuclei. Although the
staining for FrzB-2 and apoptosis was most apparent in
the chondrocyte clones it was not possible to detect the
staining in the same cells in serial sections. In addition to
the positive FrzB-2 immunostaining and apoptosis, many
cloning cells also demonstrated FrzB-2 mRNA expression
by in situ hybridization (Figs 4 and 5).
Osteoarthritis and Cartilage Vol. 8 No. 6 459Fig. 4. In situ hybridization demonstrates FrzB-2 mRNA in human OA articular chondrocytes. Cryostat sections of adult human articular
cartilage were hybridized with 35S-labeled riboprobes for FrzB-2. (a) No FrzB-2 mRNA was detected in chondrocytes (arrows) in normal
articular cartilage. Original magnification ×20. (b) Chondrocytes (arrows) in articular cartilage with early OA expressed low to moderate
(+–+ +) levels of Frzb-2 mRNA. Original magnification ×20. (c) Cloning chondrocytes (arrowheads) in the superficial zone of advanced OA
articular cartilage demonstrated intense (+ + +) levels of FrzB-2 mRNA. Original magnification ×40. (d) A serial cryosection of (c) hybridized
with the FrzB-2 sense strand riboprobe demonstrates no hybridization signal. Original magnification ×40.Fig. 5. Localization of FrzB-2 protein and apoptotic nuclei in paraffin-embedded human osteoarthritic cartilage sections antibody. Microtome
sections of human osteoarthritic cartilage were either probed with the anti-FrzB-2 peptide antibody (292QEQRRTVQDKKKTA305) or were
probed for apoptosis using a Tunel-based assay, as described in the materials and methods. Arrows indicate chondrocytes positive for
FrzB-2 protein in the left panel (red staining) and apoptotic nuclei in the right panel (brown staining). Original magnification ×20.
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There is compelling evidence from the literature to
suggest that the SFRPs may play a role in cartilage
homeostasis. FrzB-1, for example, is expressed in
chondrocytes in cartilage rudiments and at sites of long
bone growth during development.11 In addition, partially
purified extracts from newborn articular cartilage, that con-
tained FrzB-1, were found to be chondrogenic when
implanted subcutaneously into rats.20
In this study, a novel human secreted frizzled-related
protein (SFRP) and a homologue of FrzB-1, termed FrzB-2,
has been identified and characterized. We demonstrate, by
in situ hybridization and immunocytochemistry, that FrzB-2
mRNA and protein are detected in cloning chondrocytes
present in OA-derived articular cartilage sections. In
addition, the expression of FrzB-2 protein in these clones
was shown to coincide with the presence of Tunel-positive
chondrocyte nuclei. These data suggest that FrzB-2 may
play a direct role in controlling chondrocytic apoptosis and,
therefore, in the progression of the osteoarthritic process.
Although it remains to be determined definitively whetherFrzB-2 is pro- or anti-apoptotic, our data might suggest that
it is the latter. Although we demonstrate the presence of
both apoptotic nuclei and FrzB-2 protein in the chondrocyte
clones in osteoarthritic cartilage, we have not been able to
co-localize them in cells in serial sections. A recent report
suggests that there is homology between the netrin domain
of FrzB-2 and that of the tissue inhibitor of metallo-
proteinases (TIMPS) family.10 It is tempting to speculate
that FrzB-2 is up-regulated in osteoarthritic cartilage as an
attempt by the functionally compromised chondrocytes to
prevent metalloproteinase-mediated matrix degradation via
this domain. Inhibition of matrix degradation by TIMP-1
may then protect the chondrocytes from apoptosis as has
been described in murine epithelial cells.21
One approach to determine the role of FrzB-2 in apop-
tosis would be to examine chondrocyte apoptosis in the
presence of recombinant FrzB-2. Unfortunately, the iso-
lation of biologically active recombinant FrzB-2 for in vitro
study has proven problematic. This also appears to be
the case for many investigators using various expression
systems, attempting to isolate Wnt proteins. Like theTable I
FrzB-2 mRNA expression in cartilage by in situ hybridization
Sample ID Diagnosis Cell populations analyzed In situ
hybridization
HUP 98.6 Normal Superficial zone chondrocytes −
Mid-zone chondrocytes −
Deep zone chondrocytes −
HUP 98.7 Mild surface fissuring Superficial zone chondrocytes ±–+
Mid-zone chondrocytes −
Deep zone chondrocytes −
HUP 98.21 Early OA Superficial zone chondrocytes ±–+
Mid-zone chondrocytes ±–+
Deep zone chondrocytes −
IIAM 7 Surface abnormalities Superficial zone chondrocytes +
Mid-zone chondrocytes −
Deep zone chondrocytes −
IIAM 3 Mild surface fissuring
with abnormalities and
proteoglycan loss
Superficial zone chondrocytes +–+ + +
Mid-zone chondrocytes +
Deep zone chondrocytes −
HUP 98.5 Normal to advanced OA Superficial zone chondrocytes, fissuring +
Chondrocytes, normal −
Mid-zone chondrocytes −
Deep zone chondrocytes −
HUP 98.19 Normal to early OA Superficial zone chondrocytes + +
Mid-zone chondrocytes ±
Deep zone chondrocytes ±
HUP 98.10 Early OA Superficial zone chondrocytes +–+ +
Mid-zone chondrocytes −
Deep zone chondrocytes −
HUP 98.10 Advanced OA Superficial zone chondrocytes, clones + + +
Mid-zone chondrocytes +
Deep zone chondrocytes ±
HUP 98.19 Advanced OA Superficial zone chondrocytes, clones + + +
Mid-zone chondrocytes + +
Deep zone chondrocytes +
HUP 98.20 Advanced OA Superficial zone chondrocytes, clones + + +–+ + + +
Mid-zone chondrocytes + +
Deep zone chondrocytes +
Cryostat sections of human articular cartilage were screened for FrzB-2 mRNA by in situ hybridization as
described in the methods section. Samples from the tibial plateau and femoral condyl were used (patients, both
male and female ranged in aged from 16–71 years). The diagnosis (normal to OA) was made according to the
degree of fissuring that was evident in the tissues. The extent of hybridization signal was assessed by the
autoradiographic grain density over the cell and was scored in a range from ± to + + + +, corresponding to just
over background levels through intense levels of expression. In all cases the sense controls were classified as
negative.
Osteoarthritis and Cartilage Vol. 8 No. 6 461Wnts,22 secretion of the FrzB-2 protein was prevented by
its tendency to adhere to either the cell surface or the
extracellular matrix. It has previously been demonstrated
that recombinant human cathepsin K is efficiently secreted
using the baculovirus expression system.23 However,
replacement of the endogenous signal sequence of FrzB-2
with that of cathepsin K did not prevent FrzB-2 from
adhering to the expressing cells (data not shown). Also,
previous studies with Wnt expression systems have
demonstrated that cell-bound protein can be solubilized by
the addition of suramin to the cultures.24 Although this
treatment significantly increases the amount of soluble
protein in the medium, the protein is not biologically
active.25,26
The expression of FrzB-2 mRNA was not restricted to
cartilage tissues. Indeed, FrzB-2 mRNA was also detected
in ovary, testis and spleen, and at lower levels in a number
of other tissues, by Northern blot analysis. However, similar
analysis using quantitative PCR on mRNA isolated from a
number of non-diseased donor tissues (data not shown)
showed there was good correlation with the Northern blot
data for some tissues (e.g. prostate, liver, kidney and
brain), while others showed poor correlation (e.g. spleen,
pancreas, heart, lung and small intestine). Since many of
the tissues were cadaver-derived, these discrepancies may
reflect the state of the tissues at the time the RNA was
isolated, or perhaps the degree of apoptosis. Interestingly,
the positive data by Northern blot analysis on ovary and
prostate is supported by the data generated on DDC-4, the
rat orthologue of FrzB-2.16 DDC-4 is up-regulated during
the physiological apoptosis that accompanies the invol-
ution of the ovarian corpus luteum, mammary gland and
prostate. In other studies, a link between SFRP expression,
apoptosis and cancer is suggested: the human SFRP genetermed either SARP-215 or hsFRP,27 is either up-regulated
during apoptosis or down-regulated in breast cancer.
Abu-Jawdeh et al.28 described the tissue distribution of
frpHE, which is 100% homologous to FrzB-2. They
observed that frpHE mRNA was up-regulated in certain
endometrial and breast carcinomas and suggest that
altered expression of SFRPs may also be involved in
human carcinogenesis.
The FrzB-2 gene was mapped to human chromosome
7p14.1; this map location falls within a locus for retinitis
pigmentosa (RP9), which has been mapped to a 4.5 cm
region on 7p15.1-p13.29 Retinitis pigmentosa describes a
group of hereditary eye disorders that result in progres-
sive retinal degeneration characterized by pigmentation
and atrophy in the mid-periphery of the retina. Patients
experience night blindness and narrowing of visual
fields, with the possible development of complete blindness
in later life.29 Aberrant apoptosis is proposed as one
possible cause of this disease.30 During development
the mouse orthologue of FrzB-2, mouse SFRP-4 is
expressed throughout the neural retina in comple-
mentary gradients to SFRP5 and SFRP2.31,32 Chang
et al.31 speculated that inverse gradients of the SFRPs
might be involved in determining the polarity of photo-
receptors and perhaps other cells in the retina. Since
FrzB-2 and other SFRPs have been linked to both
apoptosis and retinal development15,31 they may play a
role in both normal retinal development and retinal
disease. It remains to be seen whether FrzB-2 plays a role
in RP9 and other apoptosis-related retinal degenerative
disorders.
In conclusion, the homology of FrzB-2 with the rat DDC-4
and human SARPs strongly suggests that FrzB-2 may play
an important role in apoptosis. Furthermore, the in situFig. 6. The polyclonal anti-FrzB-2 peptide antibody (292QEQRRTVQDKKKTA305) can be competed with specific peptide. Recombinant
human FrzB-2 protein, from baculovirus infected SF-9 cells, was separated and transferred to nitrocellulose. Lane 1 was probed with the
anti-FrzB-2 peptide antibody alone. Lane 2 was probed with antibody that had been pre-incubated with FrzB-2 peptide and this effectively
blocked the antibody reactivity against the recombinant protein.
462 I. E. James et al.: Characterization of human FrzB-2hybridization and protein localization data suggest that
FrzB-2 may play a part in the pathogenesis of OA and may
provide an important marker for this disease. Further
experiments, using FrzB-2 expression constructs trans-
fected into human chondrocyte cell lines, may help eluci-
date the role of FrzB-2 in the apoptotic events associated
with OA.
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